ADMA Biologics Stock Price, News & Analysis (NASDAQ:ADMA)

$3.58 0.01 (0.28 %)
(As of 01/16/2018 04:00 PM ET)
Previous Close$3.58
Today's Range$3.38 - $3.67
52-Week Range$2.01 - $5.74
Volume154,822 shs
Average Volume121,522 shs
Market Capitalization$92.34 million
P/E Ratio-1.79
Dividend YieldN/A
Beta2.09

About ADMA Biologics (NASDAQ:ADMA)

ADMA Biologics logoADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease.

Receive ADMA News and Ratings via Email

Sign-up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:ADMA
CUSIPN/A
Phone+1-201-4785552

Debt

Debt-to-Equity Ratio2.26%
Current Ratio2.36%
Quick Ratio1.35%

Price-To-Earnings

Trailing P/E Ratio-1.79
Forward P/E Ratio-1.57
P/E GrowthN/A

Sales & Book Value

Annual Sales$10.66 million
Price / Sales8.66
Cash FlowN/A
Price / CashN/A
Book Value($0.35) per share
Price / Book-10.23

Profitability

Trailing EPS($2.00)
Net Income$-19,510,000.00
Net Margins-35.00%
Return on Equity-76.26%
Return on Assets-9.77%

Miscellaneous

Employees92
Outstanding Shares25,790,000

ADMA Biologics (NASDAQ:ADMA) Frequently Asked Questions

What is ADMA Biologics' stock symbol?

ADMA Biologics trades on the NASDAQ under the ticker symbol "ADMA."

How were ADMA Biologics' earnings last quarter?

ADMA Biologics Inc (NASDAQ:ADMA) released its quarterly earnings results on Friday, November, 3rd. The biotechnology company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.51) by $1.10. ADMA Biologics had a negative net margin of 35.00% and a negative return on equity of 76.26%. View ADMA Biologics' Earnings History.

When will ADMA Biologics make its next earnings announcement?

ADMA Biologics is scheduled to release their next quarterly earnings announcement on Friday, February, 23rd 2018. View Earnings Estimates for ADMA Biologics.

Where is ADMA Biologics' stock going? Where will ADMA Biologics' stock price be in 2018?

2 brokerages have issued 12 month target prices for ADMA Biologics' shares. Their predictions range from $5.00 to $8.00. On average, they expect ADMA Biologics' share price to reach $6.50 in the next year. View Analyst Ratings for ADMA Biologics.

Who are some of ADMA Biologics' key competitors?

Who are ADMA Biologics' key executives?

ADMA Biologics' management team includes the folowing people:

  • Steven A. Elms, Chairman of the Board (Age 53)
  • Adam S. Grossman, President, Chief Executive Officer, Director (Age 38)
  • Jerrold B. Grossman D.P.S, Vice Chairman of the Board (Age 67)
  • Brian Lenz, Chief Financial Officer (Age 43)
  • James Mond M.D., Ph.D., Chief Scientific and Medical Officer (Age 69)
  • Bernhard R. M. Ehmer, Director (Age 62)
  • Bryant E. Fong, Independent Director
  • Dov A. Goldstein M.D., Independent Director (Age 49)
  • Lawrence P. Guiheen, Independent Director (Age 64)
  • Eric I. Richman, Independent Director (Age 55)

Who owns ADMA Biologics stock?

ADMA Biologics' stock is owned by a variety of of retail and institutional investors. Top institutional investors include AISLING CAPITAL II LP (8.00%). Company insiders that own ADMA Biologics stock include Adam S Grossman, Brian Lenz, Eric I Richman, James Mond and Jerrold B Grossman. View Institutional Ownership Trends for ADMA Biologics.

How do I buy ADMA Biologics stock?

Shares of ADMA Biologics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ADMA Biologics' stock price today?

One share of ADMA Biologics stock can currently be purchased for approximately $3.58.

How big of a company is ADMA Biologics?

ADMA Biologics has a market capitalization of $92.34 million and generates $10.66 million in revenue each year. The biotechnology company earns $-19,510,000.00 in net income (profit) each year or ($2.00) on an earnings per share basis. ADMA Biologics employs 92 workers across the globe.

How can I contact ADMA Biologics?

ADMA Biologics' mailing address is C/O Adma Biologics Inc., 465 State Route 17, RAMSEY, NJ 07446, United States. The biotechnology company can be reached via phone at +1-201-4785552 or via email at [email protected]


MarketBeat Community Rating for ADMA Biologics (ADMA)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  202
MarketBeat's community ratings are surveys of what our community members think about ADMA Biologics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ADMA Biologics (NASDAQ:ADMA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.50
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.50$6.50$13.00$13.00
Price Target Upside: 135.51% upside135.51% upside220.20% upside220.20% upside

ADMA Biologics (NASDAQ:ADMA) Consensus Price Target History

Price Target History for ADMA Biologics (NASDAQ:ADMA)

ADMA Biologics (NASDAQ:ADMA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/11/2017Maxim GroupReiterated RatingBuy -> Buy$13.00 -> $8.00LowView Rating Details
11/14/2017Raymond James FinancialUpgradeMarket Perform -> Outperform$5.00N/AView Rating Details
(Data available from 1/16/2016 forward)

Earnings

ADMA Biologics (NASDAQ:ADMA) Earnings History and Estimates Chart

Earnings by Quarter for ADMA Biologics (NASDAQ:ADMA)

ADMA Biologics (NASDAQ ADMA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/22/2018($0.33)N/AView Earnings Details
11/3/2017Q3 2017($0.51)$0.59ViewN/AView Earnings Details
8/11/2017Q2 2017($0.26)($0.55)$3.52 million$3.40 millionViewN/AView Earnings Details
5/12/2017Q1 2017($0.28)($0.51)$3.35 million$2.63 millionViewN/AView Earnings Details
2/24/2017Q4 2016($0.33)($0.35)ViewN/AView Earnings Details
11/10/2016Q3 2016($0.42)($0.34)$2.32 million$2.94 millionViewN/AView Earnings Details
8/12/2016Q2($0.39)($0.50)$2.35 million$2.27 millionViewN/AView Earnings Details
5/13/2016Q1($0.37)($0.43)$2.48 million$2.12 millionViewN/AView Earnings Details
3/23/2016Q4 2015($0.47)($0.44)ViewN/AView Earnings Details
11/10/2015Q315($0.39)($0.48)$1.50 million$1.85 millionViewN/AView Earnings Details
8/11/2015Q215($0.32)($0.37)$1.50 million$1.30 millionViewN/AView Earnings Details
5/12/2015Q115($0.32)($0.37)$1.50 million$1.50 millionViewN/AView Earnings Details
3/9/2015Q4 2014($0.38)($0.38)$1.52 million$1.41 millionViewN/AView Earnings Details
11/10/2014Q3 2014($0.37)($0.36)$1.37 millionViewN/AView Earnings Details
8/11/2014Q2 2014($0.43)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

ADMA Biologics (NASDAQ:ADMA) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.28 EPS
Next Year EPS Consensus Estimate: $-1.75 EPS

Dividends

Dividend History for ADMA Biologics (NASDAQ:ADMA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

ADMA Biologics (NASDAQ ADMA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 60.44%
Institutional Ownership Percentage: 32.78%
Insider Trades by Quarter for ADMA Biologics (NASDAQ:ADMA)
Institutional Ownership by Quarter for ADMA Biologics (NASDAQ:ADMA)

ADMA Biologics (NASDAQ ADMA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/9/2017Adam S GrossmanInsiderBuy485,000$2.15$1,042,750.00View SEC Filing  
11/9/2017Brian LenzCFOBuy6,500$2.15$13,975.0015,000View SEC Filing  
11/9/2017Eric I RichmanDirectorBuy25,000$2.15$53,750.0031,300View SEC Filing  
11/9/2017James MondCMOBuy10,000$2.15$21,500.0013,389View SEC Filing  
5/3/2016Adam S GrossmanCEOBuy200,000$6.50$1,300,000.00View SEC Filing  
5/3/2016Brian LenzCFOBuy2,500$6.50$16,250.008,500View SEC Filing  
5/3/2016James MondCMOBuy770$6.50$5,005.003,389View SEC Filing  
5/3/2016Jerrold B GrossmanDirectorBuy45,769$6.50$297,498.50View SEC Filing  
12/8/2015Adam S. GrossmanCEOBuy500$9.00$4,500.00637,268View SEC Filing  
12/7/2015Jerrold B GrossmanDirectorBuy500$9.01$4,505.0056,558View SEC Filing  
12/2/2015Adam S GrossmanCEOBuy2,250$9.15$20,587.50636,768View SEC Filing  
12/2/2015Brian LenzCFOBuy1,000$9.15$9,150.006,000View SEC Filing  
12/2/2015Jerrold B GrossmanDirectorBuy6,000$9.16$54,960.0056,058View SEC Filing  
12/1/2015Adam S GrossmanCEOBuy1,800$9.17$16,506.00View SEC Filing  
11/25/2015Adam S GrossmanCEOBuy1,800$9.18$16,524.00View SEC Filing  
11/20/2015Adam S GrossmanCEOBuy3,861$9.21$35,559.81628,418View SEC Filing  
3/19/2015Adam S GrossmanCEOBuy2,000$8.50$17,000.00View SEC Filing  
3/17/2015Adam S GrossmanCEOBuy5,500$7.98$43,890.00View SEC Filing  
3/17/2015Jerrold B GrossmanDirectorBuy500$8.01$4,005.00View SEC Filing  
3/16/2015Adam S GrossmanCEOBuy8,800$8.03$70,664.00View SEC Filing  
3/16/2015James MondCMOBuy1,250$8.02$10,025.00View SEC Filing  
3/16/2015Lawrence P GuiheenDirectorBuy1,000$7.96$7,960.00View SEC Filing  
3/13/2015Eric I RichmanDirectorBuy3,500$7.88$27,580.00View SEC Filing  
9/12/2014Adam S GrossmanCEOBuy4,300$9.57$41,151.00View SEC Filing  
8/22/2014Adam S GrossmanCEOBuy1,000$9.50$9,500.00View SEC Filing  
8/14/2014Adam S GrossmanCEOBuy2,100$9.77$20,517.00View SEC Filing  
6/18/2014Adam S GrossmanCEOBuy1,875$9.59$17,981.25View SEC Filing  
5/22/2014Adam S GrossmanCEOBuy4,226$8.15$34,441.90View SEC Filing  
5/15/2014Adam S GrossmanCEOBuy13,400$7.50$100,500.00View SEC Filing  
5/14/2014Brian LenzCFOBuy1,000$7.50$7,500.00View SEC Filing  
5/14/2014James MondCMOBuy1,315$7.60$9,994.00View SEC Filing  
12/10/2013Jerrold B GrossmanDirectorBuy3,650$7.30$26,645.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

ADMA Biologics (NASDAQ ADMA) News Headlines

Source:
DateHeadline
Brokerages Expect ADMA Biologics Inc (ADMA) to Announce ($0.51) EPSBrokerages Expect ADMA Biologics Inc (ADMA) to Announce ($0.51) EPS
www.americanbankingnews.com - January 13 at 5:06 PM
$6.68 Million in Sales Expected for ADMA Biologics Inc (ADMA) This Quarter$6.68 Million in Sales Expected for ADMA Biologics Inc (ADMA) This Quarter
www.americanbankingnews.com - January 8 at 4:36 AM
ADMA Biologics (ADMA) versus Its Competitors Head-To-Head ContrastADMA Biologics (ADMA) versus Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - December 29 at 8:08 AM
ADMA Biologics Inc (ADMA) Expected to Announce Quarterly Sales of $6.68 MillionADMA Biologics Inc (ADMA) Expected to Announce Quarterly Sales of $6.68 Million
www.americanbankingnews.com - December 23 at 5:58 AM
Zacks: Analysts Anticipate ADMA Biologics Inc (ADMA) Will Announce Earnings of -$0.51 Per ShareZacks: Analysts Anticipate ADMA Biologics Inc (ADMA) Will Announce Earnings of -$0.51 Per Share
www.americanbankingnews.com - December 21 at 3:28 PM
Analysts Anticipate ADMA Biologics Inc (ADMA) to Announce ($0.51) EPSAnalysts Anticipate ADMA Biologics Inc (ADMA) to Announce ($0.51) EPS
www.americanbankingnews.com - December 21 at 7:48 AM
Head to Head Contrast: ADMA Biologics (ADMA) & The CompetitionHead to Head Contrast: ADMA Biologics (ADMA) & The Competition
www.americanbankingnews.com - December 21 at 3:26 AM
Does ADMA Biologics Inc’s (NASDAQ:ADMA) Past Performance Indicate A Weaker Future?Does ADMA Biologics Inc’s (NASDAQ:ADMA) Past Performance Indicate A Weaker Future?
finance.yahoo.com - December 15 at 11:49 AM
ADMA Biologics (ADMA) Files BLA For Its Third Plasma Collection Center - StreetInsider.comADMA Biologics (ADMA) Files BLA For Its Third Plasma Collection Center - StreetInsider.com
www.streetinsider.com - December 11 at 3:42 PM
ADMA Biologics (ADMA) Given a $8.00 Price Target by Maxim Group AnalystsADMA Biologics (ADMA) Given a $8.00 Price Target by Maxim Group Analysts
www.americanbankingnews.com - December 11 at 3:40 PM
ADMA Files Biologics License Application For Its Third Plasma Collection CenterADMA Files Biologics License Application For Its Third Plasma Collection Center
finance.yahoo.com - December 11 at 11:58 AM
Comparing ADMA Biologics (ADMA) and Its PeersComparing ADMA Biologics (ADMA) and Its Peers
www.americanbankingnews.com - December 8 at 11:30 PM
ADMA Biologics Inc (ADMA) Expected to Post Quarterly Sales of $6.68 MillionADMA Biologics Inc (ADMA) Expected to Post Quarterly Sales of $6.68 Million
www.americanbankingnews.com - December 5 at 3:54 AM
Head-To-Head Comparison: ADMA Biologics (ADMA) versus Its PeersHead-To-Head Comparison: ADMA Biologics (ADMA) versus Its Peers
www.americanbankingnews.com - December 1 at 9:32 PM
ETFs with exposure to ADMA Biologics, Inc. : November 29, 2017ETFs with exposure to ADMA Biologics, Inc. : November 29, 2017
finance.yahoo.com - November 29 at 11:20 AM
ADMA Biologics Inc (ADMA): What Does It Mean For Your Portfolio?ADMA Biologics Inc (ADMA): What Does It Mean For Your Portfolio?
finance.yahoo.com - November 27 at 3:23 PM
Financial Comparison: ADMA Biologics (ADMA) versus Gilead Sciences (GILD)Financial Comparison: ADMA Biologics (ADMA) versus Gilead Sciences (GILD)
www.americanbankingnews.com - November 21 at 1:52 PM
 Analysts Set $8.88 Price Target for ADMA Biologics Inc (ADMA) Analysts Set $8.88 Price Target for ADMA Biologics Inc (ADMA)
www.americanbankingnews.com - November 21 at 5:56 AM
Zacks: Analysts Set $8.88 Target Price for ADMA Biologics Inc (ADMA)Zacks: Analysts Set $8.88 Target Price for ADMA Biologics Inc (ADMA)
www.americanbankingnews.com - November 17 at 7:16 PM
ADMA Biologics (ADMA) Reports Newly Issued U.S. Patent for Immunotherapeutic CompositionsADMA Biologics (ADMA) Reports Newly Issued U.S. Patent for Immunotherapeutic Compositions
www.streetinsider.com - November 16 at 10:46 AM
Zacks: Brokerages Expect ADMA Biologics Inc (ADMA) to Announce -$0.55 EPSZacks: Brokerages Expect ADMA Biologics Inc (ADMA) to Announce -$0.55 EPS
www.americanbankingnews.com - November 15 at 7:14 AM
ADMA Biologics Inc (ADMA) Rating Increased to Outperform at Raymond James Financial, Inc.ADMA Biologics Inc (ADMA) Rating Increased to Outperform at Raymond James Financial, Inc.
www.americanbankingnews.com - November 14 at 11:08 AM
Brian Lenz Acquires 6,500 Shares of ADMA Biologics Inc (ADMA) StockBrian Lenz Acquires 6,500 Shares of ADMA Biologics Inc (ADMA) Stock
www.americanbankingnews.com - November 13 at 8:20 PM
Insider Buying: ADMA Biologics Inc (ADMA) CMO Purchases 10,000 Shares of StockInsider Buying: ADMA Biologics Inc (ADMA) CMO Purchases 10,000 Shares of Stock
www.americanbankingnews.com - November 13 at 7:52 PM
ADMA Biologics Inc (ADMA) Director Buys $53,750.00 in StockADMA Biologics Inc (ADMA) Director Buys $53,750.00 in Stock
www.americanbankingnews.com - November 13 at 6:52 PM
ADMA Biologics Announces Closing of $42M Follow-On OfferingADMA Biologics Announces Closing of $42M Follow-On Offering
finance.yahoo.com - November 13 at 6:10 PM
ADMA: Third Quarter 2017 Financial Results and Corporate UpdateADMA: Third Quarter 2017 Financial Results and Corporate Update
finance.yahoo.com - November 13 at 6:10 PM
Adam S. Grossman Buys 485,000 Shares of ADMA Biologics Inc (ADMA) StockAdam S. Grossman Buys 485,000 Shares of ADMA Biologics Inc (ADMA) Stock
www.americanbankingnews.com - November 13 at 4:21 PM
Head to Head Analysis: ADMA Biologics (ADMA) & Array BioPharma (ARRY)Head to Head Analysis: ADMA Biologics (ADMA) & Array BioPharma (ARRY)
www.americanbankingnews.com - November 12 at 10:06 PM
Are ADMA Biologics Inc’s (ADMA) Interest Costs Too High?Are ADMA Biologics Inc’s (ADMA) Interest Costs Too High?
finance.yahoo.com - November 10 at 4:05 PM
ADMA Biologics (ADMA) Prices Follow-On OfferingADMA Biologics (ADMA) Prices Follow-On Offering
www.streetinsider.com - November 10 at 8:24 AM
BRIEF-Adma Biologics prices follow-on offering of 17.0 mln sharesBRIEF-Adma Biologics prices follow-on offering of 17.0 mln shares
www.reuters.com - November 9 at 9:27 PM
ADMA Biologics Announces Pricing of Follow-On OfferingADMA Biologics Announces Pricing of Follow-On Offering
finance.yahoo.com - November 9 at 4:25 PM
BRIEF-ADMA Biologics now sees offering‍ of 13.6 mln shares of common stock - SEC filingBRIEF-ADMA Biologics now sees offering‍ of 13.6 mln shares of common stock - SEC filing
www.reuters.com - November 9 at 3:29 AM
ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017
finance.yahoo.com - November 8 at 5:24 PM
Zacks Investment Research Analysts Cut Earnings Estimates for ADMA Biologics Inc (ADMA)Zacks Investment Research Analysts Cut Earnings Estimates for ADMA Biologics Inc (ADMA)
www.americanbankingnews.com - November 8 at 12:50 PM
ETFs with exposure to ADMA Biologics, Inc. : November 7, 2017ETFs with exposure to ADMA Biologics, Inc. : November 7, 2017
finance.yahoo.com - November 7 at 4:58 PM
BRIEF-ADMA Biologics says ‍loss per share was $0.59 for fiscal quarter ended Sept 30BRIEF-ADMA Biologics says ‍loss per share was $0.59 for fiscal quarter ended Sept 30
www.reuters.com - November 4 at 4:59 PM
ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial ResultsADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 3 at 8:24 PM
Adma Biologics posts 3Q profitAdma Biologics posts 3Q profit
finance.yahoo.com - November 3 at 8:24 PM
ADMA Biologics Inc (ADMA) Scheduled to Post Earnings on WednesdayADMA Biologics Inc (ADMA) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - November 1 at 4:08 AM
Why ADMA Biologics Inc (ADMA) Could Be A BuyWhy ADMA Biologics Inc (ADMA) Could Be A Buy
finance.yahoo.com - October 27 at 5:35 PM
Zacks: Brokerages Anticipate ADMA Biologics Inc (ADMA) Will Announce Quarterly Sales of $6.86 MillionZacks: Brokerages Anticipate ADMA Biologics Inc (ADMA) Will Announce Quarterly Sales of $6.86 Million
www.americanbankingnews.com - October 27 at 9:38 AM
-$0.51 Earnings Per Share Expected for ADMA Biologics Inc (ADMA) This Quarter-$0.51 Earnings Per Share Expected for ADMA Biologics Inc (ADMA) This Quarter
www.americanbankingnews.com - October 25 at 7:08 PM
ETFs with exposure to ADMA Biologics, Inc. : October 25, 2017ETFs with exposure to ADMA Biologics, Inc. : October 25, 2017
finance.yahoo.com - October 25 at 4:16 PM
BRIEF-Adma Biologics Inc files for offering of up to $28.75‍ million of common stockBRIEF-Adma Biologics Inc files for offering of up to $28.75‍ million of common stock
www.reuters.com - October 11 at 9:02 PM
BRIEF-ADMA Biologics ‍enters into credit agreement for up to $40 mln with affiliated entities of Marathon Asset ManagementBRIEF-ADMA Biologics ‍enters into credit agreement for up to $40 mln with affiliated entities of Marathon Asset Management
www.reuters.com - October 11 at 4:00 PM
Marathon Asset Management and ADMA Biologics Complete $30 Million Debt RefinancingMarathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing
finance.yahoo.com - October 11 at 4:00 PM
$6.86 Million in Sales Expected for ADMA Biologics Inc (ADMA) This Quarter$6.86 Million in Sales Expected for ADMA Biologics Inc (ADMA) This Quarter
www.americanbankingnews.com - October 8 at 1:28 AM
ETFs with exposure to ADMA Biologics, Inc. : September 28, 2017ETFs with exposure to ADMA Biologics, Inc. : September 28, 2017
finance.yahoo.com - October 2 at 3:16 PM

SEC Filings

ADMA Biologics (NASDAQ:ADMA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

ADMA Biologics (NASDAQ:ADMA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

ADMA Biologics (NASDAQ ADMA) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.